A ABBV

Abbvie Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

AbbVie Inc is a prominent American biopharmaceutical firm, founded in 2013 as a spin-off from Abbott Laboratories, dedicated to the research, development, and commercialization of cutting-edge therapies across immunology, oncology, virology, and neuroscience. Renowned for its flagship immunology pro...

$294.89

+1.41% (+$4.10)

Volume 6.90M

52W High $298.74

52W Low $190.75

Market Cap $513.86B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 30, 2026 Beat

Actual: $3.82 vs. Consensus: $3.74

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q2 2026 Jul 31, 2026

5-Day: -1.89%

Q2 2026 Jul 30, 2026

1-Day: -2.51%

5-Day: -5.29%

Q1 2026 Apr 29, 2026

1-Day: +3.64%

5-Day: +2.09%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$17.40B	+10.3%	85.0%	37.3%	$4.22B
Q2'26	$16.99B	+10.2%	74.7%	37.9%	$3.61B
Q1'26	$15.00B	+12.4%	71.9%	31.6%	$699.0M
Q4'25	$16.62B	+10.0%	72.6%	35.0%	$1.82B
Q3'25	$15.78B	+9.1%	66.4%	12.1%	$186.0M
Q2'25	$15.42B	+6.7%	71.8%	31.7%	$938.0M
Q1'25	$13.34B	+8.4%	70.0%	28.0%	$1.29B
Q4'24	$15.10B	+5.6%	70.9%	-9.9%	-$22.0M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 30, 2026	$3.74	$3.75	$3.82	+2.14%	Beat
Q2 2026	Jul 31, 2026	$3.64	$3.39	$3.65	+0.27%	Beat
Q2 2026	Jul 30, 2026	$3.77	$3.52	--	--	--
Q1 2026	Apr 29, 2026	$2.67	$2.55	$2.65	-0.75%	Beat
Q1 2026	Apr 23, 2026	$3.01	$2.83	$2.65	-11.96%	Missed
Q4 2025	Feb 4, 2026	$2.65	$3.31	$2.71	+2.26%	Missed
Q3 2025	Nov 5, 2025	$3.27	$3.35	$1.86	-43.12%	Missed
Q3 2025	Oct 31, 2025	$1.78	$3.35	$1.86	+4.49%	Missed
Q2 2025	Jul 31, 2025	$2.91	$3.02	$2.97	+2.06%	Missed
Q1 2025	Apr 25, 2025	$2.40	$2.47	$2.46	+2.50%	Met
Q4 2024	Jan 31, 2025	$2.12	$2.20	$2.16	+1.89%	Missed
Q3 2024	Oct 30, 2024	$2.92	$3.01	$3.00	+2.74%	Met